The AAP defines proactive care as an “ evidence-based ” approach based on “intermittent use of anti-inflammatory agents (eg, ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

Arcutis will present five posters at RAD 2025 featuring long-term safety and efficacy data for Zoryve cream in children with ...

The American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD).

The disease burden of atopic dermatitis was high in pediatric patients, but factors affecting the burden differed between adolescents and children.

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

"Ongoing collaboration between pediatric primary care providers ... More information: Jennifer J. Schoch et al, Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report, Pediatrics ...